They have routinely been involved in some of the most significant cases and bring that expertise to the table on all matters. - Legal 500 US, 2022
Kirkland is fearless.
Kirkland works with clients to defend and win product liability and mass-tort actions — ranging from high-stakes individual personal-injury trials to sprawling nationwide bet-the-company federal MDL or consolidated state cases involving thousands of claims. Kirkland welcomes and wins the most challenging products cases, including those brought in difficult circumstances following extensive media coverage of product recalls, regulatory fines, and white-collar investigations.
Time and time again, Kirkland has successfully defended cases turning on complex technical and scientific issues, including cases involving the pharmaceuticals, medical devices, automotive products, tobacco products, asbestos, and chemical industries, among others. Kirkland understands the complexities of product liability because our lawyers have been making the law—setting precedent in the highest profile cases—for the better part of a century.
We succeed at all stages of litigation, including pretrial dismissals, trial verdicts, and post-trial briefing and appeals. Drawing on a deep bench of world-class trial lawyers, Kirkland is unafraid to try and win the cases believed to be unwinnable — and our opponents know it. Our clients frequently leverage Kirkland’s aggressive approach and trial record to secure favorable resolution of massive products litigations and related massive RICO and consumer-fraud class actions and governmental investigations. We carefully work with our clients to fashion a litigation strategy that comprehends and positions our clients for successful resolution of product liability and related components of today’s high stakes complex litigation.
Tier 1 Product Liability
Benchmark Litigation, 2023
Our team has handled some of the largest investigations, criminal matters and civil proceedings in history
Product Liability & Mass Torts: The Elite
Chambers USA, 2022